SHR 4640Alternative Names: SHR-4640
Latest Information Update: 03 May 2017
Price : $50
At a glance
- Originator Jiangsu Hengrui Medicine Co.
- Class Small molecules; Uricosurics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Phase I Gout
Most Recent Events
- 01 Mar 2017 Jiangsu HengRui Medicine Co completes a phase I trial in Healthy volunteers in China (NCT02890966)
- 17 Feb 2017 Jiangsu HengRui Medicine initiates a phase I drug-drug interaction trial for Gout in China (PO, Tablet) (NCT03131583)
- 01 Feb 2017 Jiangsu HengRui Medicine Co completes a phase I trial in Healthy volunteers in China (NCT02815839)